Insulet Corporation

Health Technology diabetes healthtech medical devices

Insulet Corporation, a medical device company, develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The Company offers Omnipod Insulin Management System (Omnipod System), which consists of the OmniPod, an easy-to-use continuous insulin delivery system and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of subcutaneous drugs across various therapeutic areas. Insulet Corporation sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors.

Revenue(FY, 2016)

$367 M

Market capitalization(2018-04-20)

$5 B

Type

Public

Billerica, US

Founded

2000

Size (employees)

640 (est)

Website

insulet.com

Insulet Corporation was founded in 2000 and is headquartered in Billerica, US

Report incorrect company information

Key People/Management at Insulet Corporation

Patrick Sullivan

Chairman of the Board and Chief Executive Officer

Aiman Abdel-Malek

Senior Vice President, Advanced Technology and Engineering

Bret Christensen

Senior Vice President and Chief Commercial Officer

David Colleran

Senior Vice President, Secretary and General Counsel

Deborah Gordon

Vice President, Investor Relations and Corporate Communications

Michael Levitz

Senior Vice President, Chief Financial Officer and Treasurer

Report incorrect company information

Insulet Corporation Office Locations

Insulet Corporation has offices in Billerica, Denver, Tulsa, Washington and in 11 other locations

Billerica, US (HQ)

200 600 Technology Park Dr

Show all (15)

Report incorrect company information

Insulet Corporation Financials and Metrics

Insulet Corporation Financials

Insulet Corporation's revenue was reported to be $366.99 m in FY, 2016 which is a 13.2% increase from the previous period.

Summary

USD
Revenue (Q2, 2017)	109.8 m
Gross profit (Q2, 2017)	64.6 m
Gross profit margin (Q2, 2017), %	58.9%
Net income (Q2, 2017)	(7.8 m)
EBIT (Q2, 2017)	(3.4 m)
Market capitalization (20-Apr-2018)	5 b
Cash (30-Jun-2017)	73.5 m

Insulet Corporation's current market capitalization is $5 b.

Source: SEC Filings

Income Statement

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Revenue	247.1 m	288.7 m	324.2 m	367 m
Revenue growth, %		17%	12%	13%
Cost of goods sold	134.7 m	145.4 m	176.1 m	155.9 m
Gross profit	112.4 m	143.3 m	148.2 m	211.1 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Revenue	61.1 m	69.2 m	72 m	75 m	61.2 m	75.6 m	87.3 m	81.2 m	87.3 m	94.9 m	101.7 m	109.8 m
Cost of goods sold	33.7 m	36.4 m	36.2 m	36.9 m	28.4 m	41.2 m	51.7 m	37.2 m	36.9 m	39.2 m	42.3 m	45.1 m
Gross profit	27.4 m	32.8 m	35.8 m	38 m	32.8 m	34.4 m	35.7 m	44.1 m	50.5 m	55.6 m	59.4 m	64.6 m
Gross profit Margin, %	45%	47%	50%	51%	54%	45%	41%	54%	58%	59%	58%	59%

show all

Source: SEC Filings

Balance Sheet

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Cash	149.7 m	151.2 m	122.7 m	137.2 m
Accounts Receivable	33.1 m	39.9 m	48.4 m	28.8 m
Inventories	9.5 m	13.1 m	5.7 m	35.5 m
Current Assets	198.2 m	208.2 m	190.8 m	370 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Cash	153.9 m	145.6 m	175.5 m	146.4 m	145.6 m	145.1 m	145.5 m	111.6 m	75.7 m	215.4 m	76 m	73.5 m
Accounts Receivable	34.5 m	36.7 m	41.8 m	47.1 m	36.1 m	31.8 m	31.8 m	40.5 m	38.7 m	38.5 m	40.6 m	37.8 m
Inventories	5.4 m	10.4 m	8.8 m	9.7 m	20.1 m	23.4 m	13 m	14 m	24.5 m	32.7 m	34.3 m	34 m
Current Assets	199.7 m	199.9 m	231.8 m	206.6 m	205.4 m	203.8 m	194.3 m	171.8 m	181.3 m	361.8 m	337.2 m	338.7 m

show all

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016
Net Income	(45 m)	(51.5 m)	(73.5 m)	(28.9 m)
Depreciation and Amortization	11.8 m	12.2 m	15.8 m	13.8 m
Inventories	5.4 m	(3.6 m)	(722 k)	(24.1 m)
Cash From Operating Activities	3.3 m	8.9 m	(12.6 m)	15.9 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Net Income	(42.5 m)	(6.1 m)	(35.3 m)	(46.1 m)	(11.8 m)	(27.3 m)	(46.2 m)	(12.5 m)	(16.7 m)	(19.8 m)	(10 m)	(17.7 m)
Depreciation and Amortization	8.9 m	3.1 m	6.1 m	9.2 m	3.4 m	7.1 m	11.4 m	3.4 m	6.8 m	10.5 m	3.3 m	6.7 m
Inventories	9.5 m	(985 k)	699 k	(198 k)	(7 m)	(10.3 m)	312 k	(2.6 m)	(13.1 m)	(21.3 m)	1.2 m	1.5 m
Cash From Operating Activities	6.9 m	(1 m)	(509 k)	4.3 m	(3.5 m)	(2.7 m)		(10.5 m)	(6.8 m)	(4.2 m)	(21.8 m)	(3.9 m)